Related Experiment Video
Updated: Mar 9, 2026
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Evaluation of serum interleukin- 35 level in children with persistent asthma
Maryam Khoshkhui1, Soheyla Alyasin2, Eskandar Kamali Sarvestani3
1Allergy Research Center, Mashhad University of Medical Sciences, Mashhad , Iran.
Background:
IL-35 is a novel cytokine suppressing the immune response through the expansion of regulatory T cells and suppression of Th17 cell development. Few studies have been done on the effect of this cytokine in a different disease. Asthma is a complex disease that many inflammatory cells and cytokines play a role in.
Objective:
We decide to determine the difference between serum level of IL-35 in childhood asthma & healthy children.
Method:
We obtained serum samples from 44 asthmatic children between 2 and 15 years as a case group and from healthy children as a control group. IL-35 serum concentration was determined by ELISA method in both groups.
Results:
Mean serum level is 30.9 pg/ml in the case group and 30.2 pg/ml in the control group. There is no significant difference between serum level of IL-35 in asthmatic & healthy children.
Conclusions:
Our data reveal no relation between childhood asthma and serum level of IL35. So, further study will be needed to clarify effects of this cytokine in human allergic diseases.
Related Concept Videos
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...